1 Japanese Journal of Clinical Oncology, 2015, 45(4) doi: /jjco/hyv008 Advance Access Publication Date: 10 February 2015 Original Article Original Article Nine cases of carcinoma with neuroendocrine features in the head and neck: clinicopathological characteristics and clinical outcomes Takao Hamamoto 1, *, Satoshi Fujii 2, *, Masakazu Miyazaki 1, Takeshi Shinozaki 1, Toshifumi Tomioka 1, and Ryuichi Hayashi 1 1 Division of Head and Neck Surgery, National Cancer Center Hospital East, Chiba, and 2 Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Chiba, Japan *For reprints and all correspondence: Takao Hamamoto, Department of Otorhinolaryngology, Head and Neck Surgery, Hiroshima University Hospital, 1-2-3, Kasumi, Hiroshima , Japan; Division of Head and Neck Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba , Japan. Satoshi Fujii, Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba , Japan. Received 12 March 2014; Accepted 9 January 2015 Abstract Objective: As neuroendocrine carcinomas in the head and neck region are extremely rare, their clinicopathological characteristics remain largely unknown. Moreover, the 2005 World Health Organization classification criteria for head and neck carcinomas with neuroendocrine features have numerous limitations. Therefore, the clinicopathological features and patient outcomes of these tumors must be clarified. Methods: Between 2007 and 2012, we encountered nine cases of head and neck cancer involving a neuroendocrine carcinoma component. We investigated these tumors according to the 2010 World Health Organization classification criteria for neuroendocrine tumors, and their clinicopathological characteristics and clinical outcomes were examined. Results: Carcinomas with neuroendocrine features were found to have an aggressive clinical course, which corresponded with the Ki-67 index and mitotic count. Conclusions: Owing to the difficulty in appropriately diagnosing head and neck carcinomas with neuroendocrine features using the current classification system, a new classification system should be developed for use in these cases. Key words: neuroendocrine carcinoma, head and neck, small-cell carcinoma, immunohistochemistry Introduction Neuroendocrine carcinomas (NECs) may, on rare occasions, arise in the head and neck region, including in the larynx, nasal cavity or paranasal cavities (1 3). The 2005 World Health Organization (WHO) classification criteria outlined a classification system for NECs in the larynx, in which these tumors were classified into four types: (i) typical carcinoid; (ii) atypical carcinoid; (iii) small-cell carcinoma, neuroendocrine type and (iv) combined small-cell carcinoma, neuroendocrine type, with non-small-cell carcinoma (4). However, the 2005 WHO classification criteria for NECs in the head and neck region have some limitations. First, large cell NEC is wrongly classified as atypical carcinoid, a malignancy commonly confused with carcinoma and which cannot be clearly distinguished from NEC. Additionally, this classification lacks specific definitions on how to diagnose carcinomas with neuroendocrine features and regarding the quantity of neuroendocrine component needed for the tumor to be classified as combined NEC upon immunohistochemical analysis. The Author Published by Oxford University Press. All rights reserved. For Permissions, please 328
2 Jpn J Clin Oncol, 2015, Vol. 45, No In 2010, the WHO released their latest updated classification criteria for NECs in the gastrointestinal tract and pancreas (5). According to these criteria, all neuroendocrine neoplasms are referred to as being potentially malignant. This classification system divides neuroendocrine neoplasms into neuroendocrine tumor (NET) Grade 1, NET Grade 2 and NEC, based on morphological criteria and assessment of the proliferative rate using the Ki-67 index and mitotic counts, as summarized in Table 1. As previous studies have reported that evaluation of the tumor proliferative rate may also be of prognostic significance for tumors in the head and neck region (3,6,7), we recognized that the suitability of the 2010 WHO classification for this region should be investigated. Between 2007 and 2012, we encountered nine cases of carcinoma with neuroendocrine features in our hospital. We investigated the clinical outcomes and clinicopathological characteristics of these tumors. The purpose of this study was to investigate these tumors in view of the 2010 WHO classification, which is based on analyses of the proliferative rate using the Ki-67 index, mitotic counts and the expression of the tumor suppressor p53. Patients and methods Between January 2007 and December 2012, we encountered nine cases of carcinoma with neuroendocrine features at the National Cancer Center Hospital East, Chiba, Japan, which were all diagnosed in accordance with the 2005 WHO classification criteria using primary surgically resected specimens. The clinicopathological records were reviewed and evaluated retrospectively after the institutional review board of the National Cancer Center approved all protocols. Information regarding the patients sex, age, primary tumor site, clinical history, staging evaluation according to the American Joint Committee on Cancer TNM staging manual, treatment history and outcome was collected from documented clinical reports and imaging findings. Histopathological and immunohistochemical analyses were routinely performed in our institution using formalin-fixed and paraffinembedded tissue blocks with surgically resected specimens. Neuroendocrine features can be detected by immunohistochemical staining using neuroendocrine cell differentiation markers such as chromogranin A, synaptophysin, cluster of differentiation (CD)56, ASH1L [(absent, small or homeotic)-like (Drosophila)], and β-1,3-glucuronyltransferase 1, among others (4). However, as these markers are not sufficiently sensitive or specific individually, a combination of markers should be examined to demonstrate the existence of histopathological neuroendocrine features. In our hospital, routine immunohistochemical staining of tumors using anti-chromogranin A (LK2H10, Roche Diagnostics Corporation), synaptophysin (MRQ-40, Roche Diagnostics Corporation), CD56 (MRQ-42, Roche Diagnostics Corporation) and Ki-67 (N1633, DAKO, Glostrup, Denmark) antibodies was performed using the Table 1. World Health Organization classification of neuroendocrine tumors in the gastrointestinal tract and pancreas (2010) Tumor type, grade Mitoses (/10 HPFs) Ki-67 index (%) NET G1 <2 2% G % NEC G3 >20 >20% NET, neuroendocrine tumor; NEC, neuroendocrine carcinoma; HPF, high-power field. automated Benchmark XT platform (Ventana Medical Systems, Tucson, AZ, USA) to make a pathological diagnosis. Moreover, immunohistochemical staining using an anti-p53 polyclonal antibody (RSP53, NICHIREI BIOSCIENCES INC., Tokyo, Japan, Code No ) was performed. All tumor samples and specimens were re-evaluated by experienced pathologists in our institution in accordance with the 2010 WHO classification criteria, as summarized in Table 1. The mitotic count was determined by evaluating hematoxylin and eosin (H&E)-stained sections using a light microscope ( 400 magnification). Mitotic figures were counted at the base of the tumors in the most active area ( hot spots ) in at least 50 high-power fields (HPFs). The number of mitotic figures per 10 HPFs was calculated and presented as number per 10 HPFs. Moreover, Ki-67 expression was quantified using a visual grading system. Ki-67-positive cells were counted, and a percentage was calculated. If the staining was homogenous, the percentage of Ki-67 positive cells among the total number of carcinoma cells counted in the section was determined by counting in 10 randomly selected fields. When hot spots, defined as areas in which Ki-67 positivity was particularly prevalent, were present, the positive rate in the hot spot was recorded as the Ki-67 labeling index. All immunohistochemical staining procedures included an external control (using the same tissue section) to validate the status of Ki-67 protein expression for each case. Regarding the immunohistochemical staining of p53, in cases where >10% of the total tumor cells showed positive p53 expression, the tumor was considered p53 positive. Results All nine patients were Japanese (age range, years); had a suspected malignant tumor, as determined by analysis of the biopsy tissue; and underwent surgery as the primary treatment. The patient and clinical characteristics are summarized in Table 2. The results of the immunohistochemical staining for CD56, synaptophysin, chromogranin A, Ki-67 and p53 and the mitotic count are summarized in Table 3. Case reports Case 1: NEC of the maxillary sinus A 68-year-old man was diagnosed with a maxillary tumor (ct3n2am0) and underwent surgery. He experienced local recurrence and neck lymph node metastasis 5 months and 1 year after the operation, respectively, and hence underwent additional surgeries. Two years later, clinical investigation revealed multiple distant (mediastinum region, lung and bone) metastases. Although he underwent palliative chemotherapy, he died of the disease 6 years after the initial diagnosis. Pathological findings. H&E staining showed a poorly differentiated tumor with large alveolar structure and invasive growth to the subcutaneous tissue. The tumor cells had large, irregular-shaped nuclei, with enlarged nucleoli and eosinophilic granular cytoplasm observed, and showed partial necrosis. The tumor cells consisted of polygonal shaped cells and spindle shaped cells (Fig. 1A). The mitotic rate of the tumor was relatively low (5/10 HPFs). Immunohistochemical analyses showed positive staining for CD56, synaptophysin (Fig. 1B) and chromogranin A. The Ki-67 labeling index was high (40%), and the p53 expression was negative. Based on the above-mentioned findings, NEC was diagnosed. Case 2: NEC of the larynx A 78-year-old man was diagnosed with a larynx tumor (ct2n0m0) and underwent surgery. Two years after the first operation, he
3 330 Neuroendocrine carcinoma in the head and neck Table 2. Patients clinicopathological characteristics Case Age (year) Sex Primary site TNM stage Diagnosis Outcome Follow-up period 1 68 Male Maxilla T3N2aM0 NEC Dead 6 years 2 78 Male Larynx T2N0M0 NEC Alive 6 years 5 months 3 75 Male Hypopharynx T1N0M0 Small-cell carcinoma + SCC Alive 10 months 4 59 Male Oropharynx T2N2bM0 Small-cell carcinoma + SCC Dead 5 months 5 79 Male Larynx T3N2bM0 SCC + NEC Alive with DM 4 years 6 41 Male Unknown T0N2bM0 Spindle cell carcinoma with NEF Dead 11 months 7 66 Male Maxilla T3N0M0 SCC with NEF Dead 1 year 3 months 8 35 Male Maxilla T2N0M0 Adenocarcinoma with NEF Dead 2 years 3 months 9 64 Female Oral cavity T2N2bM0 Undifferentiated carcinoma with NEF Alive 5 years 7 months SCC, squamous cell carcinoma; NEF, neuroendocrine features; DM, distant metastasis. Table 3. Immunohistochemical findings Case CD56 Synaptophysin Chromogranin A Mitotic count (number/10 HPFs) Ki-67 index (%) p53-percentage of positive cells (%) CD56, cluster of differentiation 56. experienced recurrence in the neck lymph nodes and underwent neck dissection. At the latest follow-up, 6 years and 5 months after the initial diagnosis, he was alive with no relapse or evidence of disease. Pathological findings. Oval or polygonal tumor cells with solid growth and invasion into the subcutaneous tissue around the larynx were observed. The tumor cells had granular and eosinophilic cytoplasm and darkly stained nuclei. The mitotic rate was 7/10 HPFs (Fig. 2A). Immunohistochemical analyses showed positive staining with antibodies against synaptophysin and chromogranin A (Fig. 2B). The Ki-67 labeling index was slightly elevated (25%), and p53 expression was negative. Based on the above findings, the tumor was diagnosed as a NEC. Case 3: combined small-cell carcinoma and squamous cell carcinoma of the hypopharynx A 75-year-old man was diagnosed with a hypopharynx tumor (ct1n0m0) and underwent partial hypopharyngectomy and neck lymph node dissection. He received no adjuvant treatment after the operation, and was alive with no evidence of recurrence at the latest follow-up, 10 months after the initial diagnosis. Pathological findings. Macroscopic findings of the tumor showed two kinds of surfaces: an ash-grayish, irregular surface and a yellow flat and smooth surface. The former component consisted of polygonal tumor cells showing a solid growth pattern with keratinizing materials accompanied with intraepithelial spread. Immunohistochemistry of these tumor cells showed no evidence of neuroendocrine features, and this tumor component was accordingly diagnosed as squamous cell carcinoma (Fig. 3A). The latter tumor component was a solid alveolar component composed of closely packed cells with inconspicuous cytoplasm and round, oval-to-spindle shaped nuclei, showing a high nuclear/cytoplasmic (N/C) ratio (Fig. 3B). Immunohistochemical analyses revealed that these tumor cells showed neuroendocrine features; positive CD56, chromogranin A and synaptophysin expression. The Ki-67 index was 70%, and the p53 expression was negative. Based on the above-mentioned findings, the pathological diagnosis of this tumor was combined small-cell carcinoma and squamous cell carcinoma. Case 4: combined small-cell carcinoma and squamous cell carcinoma A 59-year-old man was diagnosed with an oropharyngeal tumor (ct2n2bm0) and underwent surgery and adjuvant radiotherapy. One month post-surgery, clinical investigation revealed multiple liver metastases, and the patient died of the disease 3 months after the initial diagnosis. Pathological findings. That tumor consisted of two co-existing components. The major component consisted of tumor cells with inconspicuous cytoplasm, showing a high N/C ratio (Fig. 4A, right). The tumor cells proliferated with solid growth, and the mitotic rate was very high (94/10 HPFs). Immunohistochemistry of this lesion showed CD56 positivity (Fig. 4B, right), but synaptophysin and chromogranin A negativity. The Ki-67 index was 70%, and the p53 expression was positive. The major tumor component was diagnosed as small-cell carcinoma. The second, minor component consisted of polygonal cells showing keratinizing or stratified differentiation (Fig. 4A, left). Immunohistochemistry of this lesion showed no evidence of neuroendocrine features, and the component was diagnosed as squamous cell carcinoma (Fig. 4B, left). Based on the findings described above, the tumor was diagnosed as combined small-cell carcinoma and squamous cell carcinoma.
4 Jpn J Clin Oncol, 2015, Vol. 45, No Figure 1. Case 1: neuroendocrine carcinoma (NEC) of the maxillary sinus. (A) Hematoxylin and eosin (H&E) staining. (B) Synaptophysin. Figure 2. Case 2: NEC of the larynx. (A) H&E staining. (B) Synaptophysin. Figure 3. Case 3: combined small-cell carcinoma and squamous cell carcinoma of the hypopharynx. (A) H&E staining. (B) H&E staining. Case 5: squamous cell carcinoma with neuroendocrine features A 79-year-old man was diagnosed with a laryngeal tumor (ct3n2bm0) and underwent surgery. Eighteen months post-surgery, he experienced local recurrence and underwent radiotherapy. He was alive with mediastinum lymph node metastasis at the latest follow-up, four years after the initial diagnosis. Pathological findings. The tumor consisted of a solid carcinoma component covered by squamous cell carcinoma showing intraepithelial spread. In the subepithelial part, the tumor cells formed solid growth, and multifocal necrosis was observed. The tumor cells showed moderate sized cytoplasm and irregularly shaped nuclei with increased chromatin (Fig. 5A). The mitotic rate of the tumor cells was high (36/ 10 HPFs). Immunohistochemical staining showed strong reactivity for CD56 (Fig. 5B) and positivity for p53 (90%) in the latter tumor component. High positivity of p53 was also observed in the former squamous cell carcinoma component. The Ki-67 index was 50%. Based on the above-mentioned findings, the pathological diagnosis of this tumor was squamous cell carcinoma with neuroendocrine features.
5 332 Neuroendocrine carcinoma in the head and neck Figure 4. Case 4: combined small-cell carcinoma and squamous cell carcinoma. (A) H&E staining. (B) CD56. Figure 5. Case 5: squamous cell carcinoma with neuroendocrine features. (A) H&E staining. (B) CD56. Figure 6. Case 6: metastatic spindle cell carcinoma with neuroendocrine features. (A) H&E staining. (B) CD56. Case 6: metastatic spindle cell carcinoma with neuroendocrine features A 41-year-old man was diagnosed with an unknown primary tumor (ct0n2bm0) and underwent neck dissection. Six months after the initial operation, follow-up computed tomography (CT) imaging revealed an adrenal gland tumor, multiple liver metastases and peritoneal dissemination. CT-guided fine needle aspiration of the adrenal tumor revealed identical pathological features as the original neck lymph node metastasis. The patient underwent palliative chemotherapy but died of the disease 11 months after the initial diagnosis. Pathological findings. The histological assessment showed spindle cell proliferation with bundle formation and multifocal necrosis (Fig. 6A). The tumor cells showed apoptosis and frequent mitoses (mitotic rate, 11/10 HPFs). Immunohistochemistry showed multifocal positivity for CD56 in the whole tumor (Fig. 6B). The Ki-67 index was 50%, and the
6 Jpn J Clin Oncol, 2015, Vol. 45, No Figure 7. Case 7: squamous cell carcinoma with neuroendocrine features. (A) H&E staining. (B) Synaptophysin. Figure 8. Case 8: adenocarcinoma with neuroendocrine features. (A) H&E staining. (B) CD56. p53 expression was positive. The findings described above were consistent with metastatic spindle cell carcinoma with neuroendocrine features. Case 7: squamous cell carcinoma with neuroendocrine features A 66-year-old man was diagnosed with maxillary carcinoma (ct3n0m0) and underwent partial maxillectomy along with adjuvant chemo-radiotherapy. One year after his first treatment, clinical investigation revealed neck lymph node metastasis and multiple distant (mediastinum, lung and bone) metastases. Although he underwent palliative chemotherapy, he died of the disease 2 years and 3 months after the initial diagnosis. Pathological findings. The tumor consisted of polygonal cells showing solid growth. However, undifferentiated cells with alveolar configuration were also observed (Fig. 7A). The mitotic rate was very high (95/ 10 HPFs). Immunohistochemistry of these undifferentiated cells showed neuroendocrine features; positive expression of CD56 and synaptophysin (Fig. 7B) with a high Ki-67 index (70%). The p53 expression was positive. Accordingly, the tumor was diagnosed as squamous cell carcinoma with neuroendocrine features. Case 8: adenocarcinoma with neuroendocrine features A 66-year-old man was diagnosed with a maxillary tumor (ct2n0m0) and underwent partial maxillectomy. Six months post-surgery, he experienced local recurrence and underwent chemo-radiotherapy. In spite of the chemo-radiotherapy, the tumor enlarged and the patient died of the disease 2 years and 3 months after the initial diagnosis. Pathological findings. The tumor consisted of polygonal tumor cells, which showed a high N/C ratio and a high mitotic rate (88/10 HPFs), with solid alveolar growth and myxomatous stroma. The tumor cells showed a partial duct-like configuration (Fig. 8A) filled with Alcian Blue-periodic acid-schiff-positive mucus materials, with neutrophils infiltrate observed inside of, and around, the tumor alveolar structure. Immunohistochemical analysis revealed that the tumor cells showed neuroendocrine features; positive expression of CD56 (Fig. 8B) and chromogranin A. The Ki-67 index was 60%, and p53 expression was negative. Based on these findings, the tumor was diagnosed as adenocarcinoma with neuroendocrine features. Case 9: undifferentiated carcinoma with neuroendocrine features A 64-year-old woman was diagnosed with oral carcinoma (ct2n2bm0) and underwent surgery. She received no adjuvant treatment and was alive with no evidence of recurrence at the latest follow-up, 5 years and 7 months after the initial diagnosis. Pathological findings. The tumor consisted of polygonal shaped and undifferentiated tumor cells showing solid growth with cobblestone appearance, and ulcer formation was observed. Most of the tumor cells
7 334 Neuroendocrine carcinoma in the head and neck Figure 9. Case 9: undifferentiated carcinoma with neuroendocrine features. (A) H&E staining. (B) CD56. were medium sized, and had oval-round nuclei with increased chromatin and a high N/C ratio (Fig. 9A). Some scattered large tumor cells with abnormal mitosis were observed, and the mitotic rate was very high (69/10 HPFs). No evidence of obvious keratinization or glandular differentiation was found, and the tumor was hence diagnosed as undifferentiated carcinoma. Immunohistochemistry showed neuroendocrine features ( positive CD56 expression) (Fig. 9B), the Ki-67 index was 80%, and p53 expression was negative, suggesting a diagnosis of undifferentiated carcinoma with neuroendocrine features. Discussion We here reported on our experiences with nine cases of carcinoma with neuroendocrine features. The pathological findings of these carcinomas showed various characteristics and could be broadly categorized into three groups: Group 1: tumors composed of pure NEC cells without any other carcinoma component (Cases 1 and 2), Group 2: NEC component and other carcinoma component existing in the same tumor, designated as combined tumor with a demarcated border (Case 3, 4 and 5) and Group 3: tumors diagnosed as ordinary carcinoma accompanied with neuroendocrine features observed upon immunohistochemical analysis (Case 6, 7, 8 and 9). Almost all of these tumors showed aggressive clinical courses with early recurrence and distant metastasis, which had been detected clinically even in the early stages. In the 2005 WHO classification, no standard definition specifically describes the quantity of neuroendocrine components required for classification as NECs. In other words, there is no definition to distinguish between combined carcinoma, in which NEC and another carcinoma coexist (Group 2), and mixed carcinoma, in which the ordinary carcinoma such as squamous cell carcinoma and adenocarcinoma shows neuroendocrine features (Group 3). In recent years, the head and neck pathology community has reached the consensus that the current WHO classification of head and neck carcinomas does not adequately describe the clinicopathological spectrum of NECs in the head and neck (3,8,9), and Xu et al. (10) recently proposed a new classification of NECs based on some elements of the 2010 WHO classification. Although current data are not sufficient to support incorporation of the Ki-67 index as a grading system of NECs in the head and neck region, several recent studies have nonetheless reported high MIB-1 labeling indices of NECs in this region (8,9,11). With regard to the diagnosis of NEC, the 2010 WHO classification appears to be useful for the evaluation of malignant potential based on proliferation kinetics and may also be of prognostic significance. Based on our results herein, we believe that, although head and neck carcinomas with neuroendocrine features are currently not diagnosed fully in accordance with the conventional WHO classification criteria, they could potentially be classified as NECs, based on both the Ki-67 index and mitotic count, which correspond with the 2010 WHO criteria for NECs. In conclusion, based on our experiences in this study, we believe that carcinomas with neuroendocrine features may be diagnosed as NECs. As these carcinomas have an aggressive behavior and poor prognosis, correct classification is crucial for proper disease management. Because there is some difficulty in appropriately diagnosing NEC using the 2005 WHO classification system, we recommend that the new (2010) classification system should instead be adapted for use in the head and neck region. However, further studies are needed to improve our understanding of the clinicopathological features of NEC and to establish the appropriate treatment strategies. Acknowledgements The authors thank Dr T. Mukaigawa (National Cancer Center Hospital East, Chiba, Japan) for his helpful suggestions and S. Yanagi (National Cancer Center Hospital East, Chiba, Japan) for technical support. Conflict of interest statement None declared. References 1. Ferlito A, Devaney KO, Rinaldo A. Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol 2006;42: Ferlito A, Silver CE, Bradford CR, Rinaldo A. Neuroendocrine neoplasms of the larynx: an overview. Head Neck 2009;31: Lewis JS Jr, Ferlito A, Gnepp DR, et al. Terminology and classification of neuroendocrine neoplasms of the larynx. Laryngoscope 2011;121:
8 Jpn J Clin Oncol, 2015, Vol. 45, No Barnes LE, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumours. In: World Health Organization Classification of Tumours. Lyon: IARC Press Bosman FTCF, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System. 4th edn. Lyon: International Agency for Research on Cancer 2010; Freudlsperger C, Rohleder SE, Reinert S, Hoffmann J. Predictive value of high Ki-67 expression in stage I oral squamous cell carcinoma specimens after primary surgery. Head Neck 2011;33: Grabenbauer GG, Mühlfriedel C, Rödel F, et al. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2000;48: Kao HL, Chang WC, Li WY, Chia-Heng Li A, Fen-Yau Li A. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis. Am J Surg Pathol 2012;36: Lewis JS Jr, Spence DC, Chiosea S, Barnes EL Jr, Brandwein-Gensler M, El-Mofty SK. Large cell neuroendocrine carcinoma of the larynx: definition of an entity. Head Neck Pathol 2010;4: Xu B, Chetty R, Perez-Ordoñez B. Neuroendocrine neoplasms of the head and neck: some suggestions for the new WHO classification of head and neck tumors. Head Neck Pathol 2014;8: Kusafuka K, Abe M, Iida Y, et al. Mucosal large cell neuroendocrine carcinoma of the head and neck regions in Japanese patients: a distinct clinicopathological entity. J Clin Pathol 2012;65:704 9.
Kobe J. Med. Sci., Vol. 49, No. 2, pp. 45-49, 2003 Central Poorly Differentiated Adenocarcinoma of the Maxilla: Report of a Case MASAHIRO UMEDA 1), SATOSHI YOKOO 1), YASUYUKI SHIBUYA 1), TAKAHIDE KOMORI
Case Reports in Otolaryngology Volume 2013, Article ID 384238, 4 pages http://dx.doi.org/10.1155/2013/384238 Case Report A Case of Primary Submandibular Gland Oncocytic Carcinoma Kunihiko Tokashiki, Kiyoaki
Diagnosis and Classification of Neuroendocrine Lung Tumors Jeffrey L. Myers, M.D. A. James French Professor Director, Anatomic Pathology & MLabs University of Michigan, Ann Arbor, MI email@example.com
Case Reports in Otolaryngology Volume 2012, Article ID 717251, 5 pages doi:10.1155/2012/717251 Case Report A Case of Typical Carcinoid of the Larynx Shintaro Sato, 1 Yuichiro Kuratomi, 1 Fumio Yamasaki,
Case Report Sarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia Jagtap Sunil V. 1, Shukla Dhirajkumar B. 2, Jagtap Swati S. 3, Havle Abhay D. 4 1 Associate Professor, Department
Case Reports in Medicine Volume 2015, Article ID 742920, 4 pages http://dx.doi.org/10.1155/2015/742920 Case Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor Omer Alici,
Sentani K et al. 1 Letter to the editor Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma Kazuhiro Sentani, 1 Takashi Tashiro, 2 Naohide Oue, 1 Wataru Yasui 1 1 Department
Carcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY SEARCHING FOR THE PRIMARY? P r o f J P P r e t o r i u s H e a d : C l i n i c a l U n i t C r i t i c a l C a r e U n i v e r s i t y O f
THYMIC CARCINOMAS AN UPDATE Mark R. Wick, M.D. University of Virginia Medical Center Charlottesville, VA CARCINOMA OF THE THYMUS General Clinical Features No apparent gender predilection Age range of 35-75
DOI 10.1007/s12105-017-0832-z CASE REPORT Low-Grade Papillary Schneiderian Carcinoma: A Case Report Hui Jeong Jeong 1 Jin Roh 1 Bong Jae Lee 2 Kyung Ja Cho 1 Received: 13 March 2017 / Accepted: 13 June
Anatomopathology Pathology 1 Anatomopathology Biopsies Frozen section Surgical specimen Peculiarities for various tumor site References Pathology 2 Biopsies Minimum data, which should be given by the pathologist
Case Reports in Surgery Volume 2013, Article ID 560712, 4 pages http://dx.doi.org/10.1155/2013/560712 Case Report Five-Year Survival after Surgery for Invasive Micropapillary Carcinoma of the Stomach Shigeo
Case Scenario 1: Thyroid History and Physical Patient is an otherwise healthy 80 year old female with the complaint of a neck mass first noticed two weeks ago. The mass has increased in size and is palpable.
Case Reports Jpn J Clin Oncol 2011;41(6)797 802 doi:10.1093/jjco/hyr034 Advance Access Publication 16 March 2011 Combined Large Cell Neuroendocrine Carcinoma and Spindle Cell Carcinoma of the Lung Taichiro
Respiratory Tract Cytology 40 th European Congress of Cytology Liverpool, UK Momin T. Siddiqui M.D. Professor of Pathology and Laboratory Medicine Director of Cytopathology Emory University Hospital, Atlanta,
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
Common Problems in Gynecologic Pathology Michael T. Deavers, M.D. Houston Methodist Hospital, Houston, Texas Common Problems in Gynecologic Pathology Adenocarcinoma in-situ (AIS) of the Cervix vs. Invasive
Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which
LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS William D. Travis, M.D. Attending Thoracic Pathologist Memorial Sloan Kettering Cancer Center New York, NY PULMONARY NE TUMORS CLASSIFICATION
Case 2 Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset History 24 year old male presented with a 3 day history of right flank pain, sharp in nature Denies fever, chills, hematuria or
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
Malaysian J Pathol 2015; 37(3) : 281 285 CASE REPORT Malignant transformation of breast ductal adenoma: a diagnostic pitfall Hiroko HAYASHI, Hiroshi OHTANI,* Junzo YAMAGUCHI,** and Isao SHIMOKAWA Department
Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14 Contents 14. Neuroendocrine Tumours 161 14.1. Diagnostic algorithm
doi: 10.1155/2016/7532805 Case Reports in Dentistry Volume 2016, Article ID 7532805, 6 pages http://dx.doi.org/10.1155/2016/7532805 Case Report A Case of Primary Combined Squamous Cell Carcinoma with Neuroendocrine
Int J Clin Exp Pathol 2014;7(5):2678-2682 www.ijcep.com /ISSN:1936-2625/IJCEP0000232 Case Report Primary small cell neuroendocrine carcinoma of the tonsil: a case report and review of the literature Hai-Yang
Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
Human Papillomavirus and Head and Neck Cancer Ed Stelow, MD No conflict of interest Declaration Cancer 1974 Lancet Oncol 2016; 17: e477-8 JAMA 1984; 252: 1857 JAMA 1988;259(13):1943-1944 Clin Cancer Res
& 2004 USCAP, Inc All rights reserved 0893-3952/04 $25.00 www.modernpathology.org Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical
Pulmonary Pathology Specialty Conference Saul Suster, M.D. Medical College of Wisconsin Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position
GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
Reporting HPV related carcinomas of the head and neck dr. Nina Zidar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia Conflict of interest/funding X None Company: Product royalties
Follicular Derived Thyroid Tumors Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical Sciences
1166 Clinical analysis of 29 cases of nasal mucosal malignant melanoma HUANXIN YU and GANG LIU Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Huanhu Hospital, Tianjin 300060, P.R. China
A 33-year-old male with a left lower leg mass. Contributed by Shaoxiong Chen, MD, PhD Assistant Professor Indiana University School of Medicine/ IU Health Partners Department of Pathology and Laboratory
Int J Clin Exp Pathol 2014;7(4):1809-1813 www.ijcep.com /ISSN:1936-2625/IJCEP1402024 Letter to Editor Adenosquamous carcinoma of the tongue: a case report with review of the literature Mitsuaki Ishida,
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction
Squamous Cell Carcinoma of Thyroid: possible thymic origin, so-called ITET/CASTLE 2012/03/22 History of ITET/CASTLE First Report Gross Appearance and Prognosis 1) Miyauchi A et al: Intrathyroidal epithelial
of breast - a case report and distinction with metaplastic carcinoma D Gupta, S Agrawal, N Trivedi, A Tewari Introduction, also known as mixed tumour, is a benign tumour which typically presents as a painless,
ISPUB.COM The Internet Journal of Pathology Volume 8 Number 2 Solid pseudopapillary tumour of the pancreas: Report of five cases P Srilatha, V Manna, P Kanthilatha Citation P Srilatha, V Manna, P Kanthilatha..
Epithelial tumors Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev Epithelial tumors Tumors from the epithelium are the most frequent among tumors. There are 2 group features of these tumors: The presence in most
doi: 10.2169/internalmedicine.1700-18 http://internmed.jp CASE REPORT Usefulness of Capsule Endoscopy and Double-balloon Enteroscopy for the Diagnosis of Multiple Carcinoid Tumors in the Small Intestine:
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate
November 2015 Case of the Month A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy. Contributed by: Rasha Salama, M.D., IU Department of Pathology and Laboratory Medicine
Neoplasia 2018 Lecture 2 Dr Heyam Awad MD, FRCPath ILOS 1. List the differences between benign and malignant tumors. 2. Recognize the histological features of malignancy. 3. Define dysplasia and understand
Oral Cavity 1. Introduction 1.1 General Information and Aetiology The oral cavity extends from the lips to the palatoglossal folds and consists of the anterior two thirds of the tongue, floor of the mouth,
Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.
Case Report Diagnosis of a granular cell tumour at the abdominal wall using fine needle aspiration cytology and histology: Case report Journal of International Medical Research 2015, Vol. 43(4) 592 596!
Hyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000 Thomas A. Bonfiglio, M.D. Professor Emeritus, Pathology and Laboratory Medicine University of Rochester Disclosures In the past 12 months,
Human Papillomavirus Testing in Head and Neck Carcinomas Guideline from the College of American Pathologists Early Online Release Publication: Archives of Pathology & Laboratory Medicine 12/18/2017 Overview
Basal cell carcinoma diagnosed on Fine-Needle Aspiration Cytology A Abstract Dr. Madhuri S.Kate 1, Dr. Preeti Jain 2, Dr. Shailesh S. Patne 3 Introduction: Basal cell carcinoma (BCC) is a locally invasive
Hypopharynx 1. Introduction 1.1 General Information and Aetiology The human pharynx is the part of the throat situated between the nasal cavity and the esophagus and can be divided into three parts: the
2012 66 4 351 356 Serotonin- and Somatostatin-Positive Goblet Cell Carcinoid of the Duodenum a b* c c c a a b d a c b d 352 Ohara et al. received remedies at another hospital. Hematemesis then recurred
The Korean Journal of Pathology 2013; 47: 481-485 CASE STUDY Fine-Needle Aspiration Cytology of Low-Grade Cribriform Cystadenocarcinoma with Many Psammoma Bodies of the Salivary Gland Ji Yun Jeong Dongbin
CASE REPORT Endoscopic Resection of Ampullary Neuroendocrine Tumor Hiroyuki Fukasawa, Shigetaka Tounou, Masashi Nabetani and Tomoki Michida Abstract We report the case of a 57-year-old man with a 1.0-cm
May 2016 A 25 year old female with a palpable mass in the right lower quadrant of her abdomen Contributed by: Paul Ndekwe, MD, Resident Physician, Indiana University School of Department of Pathology and
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
Histological Typing Of Cancer And Precancer Of The Oral Mucosa 1 / 7 2 / 7 3 / 7 Histological Typing Of Cancer And Within the last decade, histologic grading has become widely accepted as a powerful indicator
H&N Neuroendocrine Neoplasms: Classification and Diagnostic Considerations Adel K. El-Naggar, M.D., Ph.D. The University of Texas MD Anderson Cancer Center, Houston, Texas Broad Classification: A. Epithelial:
Case Reports in Surgery Volume 2013, Article ID 812129, 4 pages http://dx.doi.org/10.1155/2013/812129 Case Report Synchronous Bilateral Solid Papillary Carcinomas of the Breast Noriko Yoshimura, 1 Shigeru
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
Carcinoma of the Lung: A Really Dismal Histologic Variant? Dae Joon Kim, MD, Kil Dong Kim, MD, Dong Hwan Shin, MD, Jae Y Ro, MD, and Kyung Young Chung, MD Departments of Thoracic and Cardiovascular Surgery,
Jichi Medical University Journal Chio Shuto Kuniyasu Soda Takayoshi Yoshida Fumio Konishi Abstract We report a very rare case of a pedunculated intraperitoneal leiomyoma in the parietal peritoneum of the
Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about
Leiomyosarcoma of the inferior vena cava: 1 case B. Bancel, A. Rode, C. Ducerf Hôpital CROIX ROUSSE LYON Bucharest Nov 2011 Case report 34 yr-old woman, no antecedent Sept 2004: Abdominal upper right quadrant
Neuroendocrine neoplasms of the lung M Papotti, L Righi, & M Volante University of Turin at San Luigi Hospital TORINO NETs OF THE LUNG Menu - Spectrum of NE lung tumors - CARCINOID TUMORS - SCLC /LCNEC
Case Reports in Pathology Volume 2015, Article ID 153932, 5 pages http://dx.doi.org/10.1155/2015/153932 Case Report Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms Shiuan-Li
ISPUB.COM The Internet Journal of Pathology Volume 8 Number 2 Oncocytic carcinoma: A rare malignancy of the parotid gland K Mardi, J Sharma Citation K Mardi, J Sharma.. The Internet Journal of Pathology.
Int Canc Conf J (2013) 2:191 195 DOI 10.1007/s13691-013-0-9 CANCER BOARD CONFERENCE Metastatic mechanism of spermatic cord tumor from stomach cancer Masahiro Seike Yoshikazu Kanazawa Ryuji Ohashi Tadashi
& 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and
Squamous cell carcinoma (SCC): A common malignant tumor of keratinocytes arising in the epidermis, usually from a precancerous condition: 1- UV induced actinic keratosis, usually of low grade malignancy.
Showa Univ J Med Sci 25 1, 67 72, March 2013 Case Report Well-differentiated Papillary Mesothelioma of the Pleura Diagnosed by Video-Assisted Thoracic Surgical Pleural Biopsy : A Case Report Yuri TOMITA
Kitakanto Med J 2002 ; 52 : 189-193 189 A Proposed Strategy for Treatment of Superficial Carcinoma in the Thoracic Esophagus Based on an Analysis of Lymph Node Metastasis Susumu Kawate,' Susumu Ohwada,'
BREAST PATHOLOGY Lesions of the breast are very common, and they present as palpable, sometimes painful, nodules or masses. Most of these lesions are benign. Breast cancer is the 2 nd most common cause
Nakamura et al. BMC Cancer (2016) 16:743 DOI 10.1186/s12885-016-2787-y RESEARCH ARTICLE Open Access Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic
Case Presentation Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD Department of Pathology Jordan University Hospital Amman, Jordan The 25th Annual Congress of the ADIAP The 8/11/2013 1 5th International